Home/Filings/4/0001711968-25-000011
4//SEC Filing

Chapman Steven Leonard 4

Accession 0001711968-25-000011

CIK 0001604821other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 9:40 PM ET

Size

20.6 KB

Accession

0001711968-25-000011

Insider Transaction Report

Form 4
Period: 2025-11-03
Chapman Steven Leonard
DirectorCEO AND PRESIDENT
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-03$20.27/sh+3,595$72,871155,519 total
  • Sale

    Common Stock

    2025-11-03$198.03/sh2,215$438,635303,304 total
  • Sale

    Common Stock

    2025-11-03$198.96/sh1,915$381,012301,389 total
  • Exercise/Conversion

    Common Stock

    2025-11-03$13.01/sh+2,084$27,113151,924 total
  • Exercise/Conversion

    Common Stock

    2025-11-03$119.75/sh+150,000$17,962,500305,519 total
  • Sale

    Common Stock

    2025-11-03$200.00/sh156,573$31,314,334144,816 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-03150,0000 total
    Exercise: $119.75Exp: 2031-01-21Common Stock (150,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-032,0840 total
    Exercise: $13.01Exp: 2029-01-10Common Stock (2,084 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-033,5950 total
    Exercise: $20.27Exp: 2029-04-11Common Stock (3,595 underlying)
Footnotes (6)
  • [F1]The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The option shares are fully exercisable.
  • [F6]On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date.

Issuer

Natera, Inc.

CIK 0001604821

Entity typeother

Related Parties

1
  • filerCIK 0001711968

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 9:40 PM ET
Size
20.6 KB